TNSN93045A1 - Nouveaux composes actifs - Google Patents
Nouveaux composes actifsInfo
- Publication number
- TNSN93045A1 TNSN93045A1 TNTNSN93045A TNSN93045A TNSN93045A1 TN SN93045 A1 TNSN93045 A1 TN SN93045A1 TN TNSN93045 A TNTNSN93045 A TN TNSN93045A TN SN93045 A TNSN93045 A TN SN93045A TN SN93045 A1 TNSN93045 A1 TN SN93045A1
- Authority
- TN
- Tunisia
- Prior art keywords
- carbohydrate
- active compounds
- immunogenic
- peptide
- new active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
LA PRESENTE INVENTION SE RAPPORTE A UNE CLASSE NOUVELLE DE COMPOSES BIOLOGIQUEMENT ACTIFS, A DES PROCEDES EN VUE DE LEUR PRODUCTION, ET A LEUR EMPLOI EN THERAPIE. PLUS PARTICULIEREMENT, L'INVENTION PORTE SUR DES CONJUGUES IMMUNOGENES UTILES POUR LA CREATION D'UNE IMMUNITE T LYMPHOCYTAIRE CONTRE DES STRUCTURES GLUCIDIQUES A ASSOCIATION TUMORALE OU CONTRE DES STRUCTURES GLUCIDIQUES EXPRIMEES SUR DES AGENTS INFECTIEUX ET/OU DES CELLULES HOTES INFECTEES. LEDIT CONJUGUE IMMUNOGENE COMPREND (1) UN ELEMENT PEPTIDE CAPABLE DE SE LIER A UNE MOLECULE MHC DE CLASSE 1 ; ET (ii) UN ELEMENT GLUCIDE AYANT LA SPECIFICITE IMMUNOGENE DE LADITE STRUCTURE GLUCIDIQUE
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201338A SE9201338D0 (sv) | 1992-04-28 | 1992-04-28 | New active compounds |
SE9202553A SE9202553D0 (sv) | 1992-09-07 | 1992-09-07 | New active compounds ii |
SE9203897A SE9203897D0 (sv) | 1992-12-23 | 1992-12-23 | New active compounds iii |
SE9301141A SE9301141D0 (sv) | 1993-04-06 | 1993-04-06 | New active compounds iv |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN93045A1 true TNSN93045A1 (fr) | 1994-03-17 |
Family
ID=27484749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN93045A TNSN93045A1 (fr) | 1992-04-28 | 1993-04-28 | Nouveaux composes actifs |
Country Status (19)
Country | Link |
---|---|
US (2) | US5807559A (fr) |
EP (1) | EP0675733B1 (fr) |
JP (1) | JPH07506358A (fr) |
CN (1) | CN1096032A (fr) |
AT (1) | ATE197903T1 (fr) |
AU (1) | AU676679B2 (fr) |
CA (1) | CA2134097A1 (fr) |
DE (1) | DE69329735T2 (fr) |
DK (1) | DK0675733T3 (fr) |
ES (1) | ES2155070T3 (fr) |
GR (1) | GR3035501T3 (fr) |
IL (1) | IL105503A (fr) |
IS (1) | IS4010A (fr) |
MA (1) | MA22885A1 (fr) |
MY (1) | MY108864A (fr) |
PT (1) | PT675733E (fr) |
SI (1) | SI9300223A (fr) |
TN (1) | TNSN93045A1 (fr) |
WO (1) | WO1993021948A1 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083929A (en) * | 1991-05-06 | 2000-07-04 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
DE4436164A1 (de) * | 1994-10-10 | 1996-04-11 | Hoechst Ag | Neue Kohlenhydratkonjugate als Inhibitoren der Zelladhäsion |
US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US6841543B1 (en) | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
US6218363B1 (en) * | 1996-08-28 | 2001-04-17 | Thomas Jefferson University | MHC peptides and methods of use |
WO1998015286A1 (fr) * | 1996-10-08 | 1998-04-16 | La Jolla Institute For Allergy & Immunology | Lymphocytes t a cytolyse specifique des glucides |
ES2265162T3 (es) * | 1997-03-27 | 2007-02-01 | Institut Pasteur | Carbohidrato glucopeptido de antigeno multiple, vacuna que comprende el mismo y su utilizacion. |
US20070237785A1 (en) * | 1997-03-27 | 2007-10-11 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
JP4308918B2 (ja) | 1997-04-16 | 2009-08-05 | スローン−ケッタリング インスティトゥート フォア キャンサー リサーチ | (2,6)−STエピトープクラスターを有するα−O−結合複合糖質、その製造方法および使用 |
US7550146B2 (en) * | 1997-04-16 | 2009-06-23 | Sloan-Kettering Institute For Cancer Research | Glycopeptide conjugates and uses thereof |
AUPO732997A0 (en) * | 1997-06-12 | 1997-07-03 | Csl Limited | Ganglioside immunostimulating complexes and uses thereof |
CA2324616A1 (fr) * | 1998-03-25 | 1999-09-30 | Sloan-Kettering Institute For Cancer Research | Conjugues de glycopeptides a liaison o antigeniques trimeres, procedes de preparation et utilisation de ceux-ci |
US7402307B2 (en) * | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
WO1999050392A1 (fr) | 1998-03-31 | 1999-10-07 | Geron Corporation | Techniques et compositions permettant de faire apparaitre une reponse immunitaire a un antigene de telomerase |
EP1073667A2 (fr) * | 1998-04-28 | 2001-02-07 | Galenica Pharmaceuticals, Inc. | Conjugues d'antigene et de polysaccharide |
US20030091546A1 (en) * | 1998-11-12 | 2003-05-15 | Barber Jack R. | Methods of suppressing immune response by gene therapy |
US7824687B2 (en) | 1999-08-20 | 2010-11-02 | Sloan-Kettering Institute For Cancer Research | Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof |
JP5111705B2 (ja) * | 1999-08-20 | 2013-01-09 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | 新規な複合多糖、グリコアミノ酸、これらへの中間体、及びこれらの使用 |
US7854934B2 (en) * | 1999-08-20 | 2010-12-21 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
DE10005275A1 (de) * | 2000-02-07 | 2001-08-09 | Bayer Ag | Neuartige Glycokonjugate |
US20030049253A1 (en) * | 2001-08-08 | 2003-03-13 | Li Frank Q. | Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines |
UA79952C2 (en) * | 2001-12-10 | 2007-08-10 | Kabulesh Mafatlal Khamar | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT |
WO2004069873A2 (fr) * | 2003-02-06 | 2004-08-19 | Tripep Ab | Echangeurs de specificite glycosyles |
EP1720567A2 (fr) * | 2004-02-10 | 2006-11-15 | Innate Pharma | Composition et procede pour le traitement de carcinome |
US20060263415A1 (en) | 2005-05-05 | 2006-11-23 | Sensient Flavors Inc. | Production of beta-glucans and mannans |
WO2007073486A2 (fr) | 2005-12-20 | 2007-06-28 | Duke University | Procedes et compositions pour l'administration d'agents actifs a proprietes pharmacologiques ameliorees |
EP2391635B1 (fr) | 2009-01-28 | 2017-04-26 | Epimmune Inc. | Polypeptides de liaison de pan-dr et leurs utilisations |
JP2013527753A (ja) | 2010-03-23 | 2013-07-04 | イントレキソン コーポレーション | 治療タンパク質を条件的に発現するベクター、該ベクターを含む宿主細胞およびそれらの使用 |
EP2500033A1 (fr) | 2011-03-17 | 2012-09-19 | Institut Pasteur | Procédé pour la préparation de plusieurs conjugués de carbohydrate de glycopeptide d'antigène |
KR102081868B1 (ko) | 2011-06-28 | 2020-02-26 | 이노비오 파마수티컬즈, 인크. | 최소 침습 피부 전기천공 장치 |
EP2606897A1 (fr) * | 2011-12-22 | 2013-06-26 | Laboratorios Del. Dr. Esteve, S.A. | Procédés et compositions pour le traitement des maladies causées par les virus enveloppés |
EP3651795A4 (fr) * | 2017-07-12 | 2021-05-26 | The Board of Trustees of the Leland Stanford Junior University | Compositions et méthodes pour le traitement de cancers présentant une mutation h3k27m |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2004744B (en) * | 1977-09-28 | 1982-05-26 | Sanderson A R | Immonulogical preparations |
CA1335883C (fr) * | 1986-07-08 | 1995-06-13 | Bryan Michael Longenecker | Stimulation de la reponse immunitaire cellulaire |
JP2921574B2 (ja) * | 1988-02-01 | 1999-07-19 | アメリカン・サイアナミド・カンパニー | 接合体ワクチンの担体分子としてのt細胞のエピトープ |
EP0400077A4 (en) * | 1988-02-12 | 1990-12-27 | The Regents Of The University Of California | Use of synthetic peptides to generate and manipulate cellular immunity |
US5229289A (en) * | 1988-03-11 | 1993-07-20 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
CA1337403C (fr) * | 1988-03-28 | 1995-10-24 | Biomembrane Institute (The) | Methodes de production d'anticorps et induction de reponses immunitaires aux gangliosides associes aux tumeurs par immunisation avec des lactones de gangliosides |
WO1991001146A1 (fr) * | 1989-07-14 | 1991-02-07 | Praxis Biologics, Inc. | Cytokine et supports d'hormone pour vaccins conjugues |
CA2067124A1 (fr) * | 1989-08-28 | 1991-03-01 | Patricia L. Domen | Vecteurs cationises pour la production d'immunogene |
GB8924438D0 (en) * | 1989-10-31 | 1989-12-20 | Hoffmann La Roche | Vaccine composition |
IT1237764B (it) * | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
-
1993
- 1993-04-22 IL IL10550393A patent/IL105503A/en not_active IP Right Cessation
- 1993-04-23 WO PCT/SE1993/000353 patent/WO1993021948A1/fr active IP Right Grant
- 1993-04-23 DK DK93912042T patent/DK0675733T3/da active
- 1993-04-23 PT PT93912042T patent/PT675733E/pt unknown
- 1993-04-23 DE DE69329735T patent/DE69329735T2/de not_active Expired - Fee Related
- 1993-04-23 AT AT93912042T patent/ATE197903T1/de not_active IP Right Cessation
- 1993-04-23 CA CA002134097A patent/CA2134097A1/fr not_active Abandoned
- 1993-04-23 JP JP5519172A patent/JPH07506358A/ja not_active Abandoned
- 1993-04-23 ES ES93912042T patent/ES2155070T3/es not_active Expired - Lifetime
- 1993-04-23 AU AU42746/93A patent/AU676679B2/en not_active Ceased
- 1993-04-23 EP EP93912042A patent/EP0675733B1/fr not_active Expired - Lifetime
- 1993-04-27 US US08/054,860 patent/US5807559A/en not_active Expired - Fee Related
- 1993-04-27 IS IS4010A patent/IS4010A/is unknown
- 1993-04-27 MA MA23178A patent/MA22885A1/fr unknown
- 1993-04-28 CN CN93106340A patent/CN1096032A/zh active Pending
- 1993-04-28 TN TNTNSN93045A patent/TNSN93045A1/fr unknown
- 1993-04-28 MY MYPI93000788A patent/MY108864A/en unknown
- 1993-04-28 SI SI9300223A patent/SI9300223A/sl unknown
-
1995
- 1995-05-16 US US08/442,378 patent/US6033669A/en not_active Expired - Fee Related
-
2001
- 2001-03-05 GR GR20010400341T patent/GR3035501T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69329735D1 (de) | 2001-01-11 |
IS4010A (is) | 1993-10-29 |
ES2155070T3 (es) | 2001-05-01 |
MY108864A (en) | 1996-11-30 |
GR3035501T3 (en) | 2001-06-29 |
US6033669A (en) | 2000-03-07 |
DK0675733T3 (da) | 2001-05-07 |
AU4274693A (en) | 1993-11-29 |
ATE197903T1 (de) | 2000-12-15 |
CN1096032A (zh) | 1994-12-07 |
IL105503A (en) | 1999-05-09 |
DE69329735T2 (de) | 2001-08-02 |
EP0675733A1 (fr) | 1995-10-11 |
WO1993021948A1 (fr) | 1993-11-11 |
MA22885A1 (fr) | 1993-12-31 |
CA2134097A1 (fr) | 1993-11-11 |
US5807559A (en) | 1998-09-15 |
IL105503A0 (en) | 1993-08-18 |
EP0675733B1 (fr) | 2000-12-06 |
PT675733E (pt) | 2001-05-31 |
SI9300223A (en) | 1994-03-31 |
AU676679B2 (en) | 1997-03-20 |
JPH07506358A (ja) | 1995-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA22885A1 (fr) | Nouveaux composes actifs. | |
BR9303469A (pt) | Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas | |
DE68906366D1 (en) | Cd4-polypeptidderivate. | |
ES2056215T3 (es) | Composiciones de detergente. | |
GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
EP1003526A4 (fr) | N, o-carboxymethyl-chitosane a liaison covalente et ses applications | |
ATE296105T1 (de) | Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel | |
DK1137430T3 (da) | Terapeutikum til undertrykkelse af snorkelyde | |
IL118603A (en) | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof | |
WO1991017773A3 (fr) | Nouveaux conjugues de proteines et de polycations | |
NZ506631A (en) | Formulations for the stabilisation of PEG-interferon alpha conjugates during and after lyophilization | |
TR199501654A3 (fr) | ||
TW218847B (fr) | ||
DE69106361D1 (de) | Einschlusskomplex von nimesulide mit cyclodextrinen. | |
AR016427A1 (es) | CONJUGADOS uTILES PARA EL TRATAMIENTO DE CÁNCER DE PRoSTATA, Y UNA COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE. | |
NZ235316A (en) | Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection | |
EP0378203A3 (fr) | Acide-hydrazide de la cobalamine et conjugués de la cobalamine en dérivant | |
AU7299591A (en) | Delivery of agents | |
JO1766B1 (en) | Effective new compounds | |
TW332816B (en) | Peptide and carbohydrate | |
FI961339A0 (fi) | Triaryylieteenijohdannaiset käytettäväksi hoidossa | |
IT8820245A0 (it) | Palmitoil_fruttosio_1,6_difosfato, suo uso terapeutico e relativi metodi di preparazione. | |
FR2652266B1 (fr) | Vaccin protecteur contre l'hemophilose porcine. | |
TH13666A (th) | สารประกอบออกฤทธิ์ชนิดใหม่ | |
NO884941L (no) | Konjugat av metallothionein eller et metallothioneinfragment og et maalsoekende biologisk aktivt molekyl, som er anvendelig som mellomprodukt ved fremstilling av lignende merkede konjugater. |